Exosome Stability Challenges in Cosmetic Formulations: A Scientific Perspective

In regenerative medicine and dermatology, exosomes (cell-secreted nanovesicles) are valued for their ability to transport biologically active molecules (proteins, lipids, RNA) and modulate intercellular communication. This potential has driven the rapid integration of exosomes into cosmetic products. However, scientific analysis reveals a significant gap between theoretical efficacy and actual biological activity in commercial formulations.

Correlation Between Temperature Regimen and Stability

The critical factor determining the biological activity of exosomes is their structural integrity. According to studies published by the National Institutes of Health (NIH) and other scientific institutions, exosomes are highly thermolabile structures.

To maintain exosome viability and functionality during long-term storage, cryogenic temperatures (typically -80°C) must be maintained. Research indicates that storing exosomes in a liquid medium at standard refrigerator temperatures (4°C) or room temperature (20–25°C) results in the rapid degradation of the lipid bilayer and internal contents. At room temperature, exosomes lose their biological activity within a few hours or days.

Limitations of Commercial Application

These thermodynamic limitations pose fundamental challenges to the traditional cosmetics supply chain. Products stored on store shelves or in consumers' homes at room temperature cannot ensure exosome viability. In most cases, only fragments of degraded vesicles remain in the final product, which can no longer perform cellular communication functions.

Furthermore, the European Union Cosmetics Regulation strictly prohibits the use of human-derived substances, leading to the dominance of phytogenic (plant-derived) exosomes in the market. While they comply with legal requirements, their thermolability issue remains analogous.

Versus Labs Technological Position

Guided by the "Safe by Science" philosophy (scientifically validated safety and efficacy), the Versus Labs laboratory critically evaluates the stability of ingredients in formulations. While we closely monitor the development of exosome stabilization technologies (e.g., lyophilization), we currently prioritize systems whose stability under standard conditions is unequivocally proven.

As a reliable alternative, we offer and continuously improve liposomal delivery systems. Unlike exosomes, liposomes can be formulated to maintain structural integrity at room temperature throughout the product's shelf life. This allows for the effective and stable transport of active substances (e.g., NMNH, peptides) into the deeper layers of the skin, ensuring a measurable and reliable outcome.